Skip to contentClarengateINTELLIGENCE
Companies/SC651132

Tay Therapeutics Limited

Research and experimental development on biotechnology · Dundee

ActiveUnited KingdomIncorporated 2020Private Limited Company
Register Ask analyst

Financial position

Accounts to 2026-01-31 · GBP · Company accounts

Net assets
£3,156,031
Cash
£1,684,712
Turnover
—
Profit / loss
—
Current assets
£2,256,199
Creditors < 1 year
£90,168
Equity
£3,156,031
Average employees
8

Balance-sheet trend

GBP · company

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

10 periods
Reported figures2026-01-31Company2025-02-01Company2025-01-31Company2024-02-01Company2024-01-31Company2023-02-012023-01-312022-02-012022-01-312021-01-31
Balance sheet
Net assets£3,156,031—£3,189,080—£3,037,622—£2,109,752—£2,531,979£970,811
Equity£3,156,031—£3,189,080—£3,037,622—£2,109,752—£2,531,979£970,811
Assets
Fixed assets—————————£0
Intangible assets£990,000£0£0——————£0
Property, plant & equipment£0£18,542£18,542£42,441£42,441£61,566£61,566£314£314£0
Current assets£2,256,199—£3,258,500—£3,272,009—£2,492,316—£2,806,489£1,005,141
Cash at bank£1,684,712—£3,067,171—£3,159,884—£1,914,571—£2,622,443£984,846
Debtors£571,487—£191,329—£112,125—£577,745—£184,046£20,295
Stock—————————£0
Liabilities
Creditors within one year£90,168—£87,962—£276,828—£444,130—£274,824£34,330
Creditors after one year—————————£0
Provisions—————————£0
Net current assets£2,166,031—£3,170,538—£2,995,181—£2,048,186—£2,531,665£970,811
Assets less current liabilities£3,156,031—£3,189,080—£3,037,622—£2,109,752—£2,531,979£970,811
People
Average employees8—12—12—8—54
Source evidenceView filing View filing View filing View filing View filing View filing View filing View filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

1 outstanding charges
All Assets · created 2022-06-21
—
Outstanding